ESDREG: Endoscopic Submucosal Dissection Registry

Sponsor
Carol Davila University of Medicine and Pharmacy (Other)
Overall Status
Recruiting
CT.gov ID
NCT06033976
Collaborator
(none)
200
1
120
1.7

Study Details

Study Description

Brief Summary

This is a patient registry for all cases of pre-neoplastic or early neoplastic digestive tract lesions treated with curative intention by endoscopic submucosal dissection (ESD) technique.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic submucosal dissection (ESD)

Detailed Description

Cases will be registered one by one in an electronic record, with the consent of the patient and respecting all legal requirements.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Endoscopic Submucosal Dissection Patients Registry in "Agrippa Ionescu" Hospital, Bucharest, Romania
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Jan 1, 2031
Anticipated Study Completion Date :
Jan 1, 2031

Outcome Measures

Primary Outcome Measures

  1. Rate of curative resection [through study completion, an average of 1 year]

Secondary Outcome Measures

  1. Rate of R0 resection [through study completion, an average of 1 year]

Other Outcome Measures

  1. Rate of perforation [30 days]

  2. Rate of delayed bleeding [30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa

  • non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric, duodenal or colorectal mucosa

  • age > 18 years old

  • informed consent

Exclusion Criteria:
  • age < 18 years old

  • no informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Agrippa Ionescu" Hospital Bucharest Romania

Sponsors and Collaborators

  • Carol Davila University of Medicine and Pharmacy

Investigators

  • Principal Investigator: Mihai L Ciocirlan, Associate Professor, Carol Davila University of Medicine and Pharmacy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mihai Ciocirlan, Clinical Professor (Associate Professor), Carol Davila University of Medicine and Pharmacy
ClinicalTrials.gov Identifier:
NCT06033976
Other Study ID Numbers:
  • ESDREG
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023